Skip to main content
LMB logo

LMB · Limbach Holdings, Inc.

Track LMB — free
$48.93 +0.98 (+2.04%) At close · Sep 30
Market Cap
$613.90M
Shares
11.92M
Volume · Sep 30 363.08K Avg daily vol (3M) 350.83K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$48.93 Open$48.46 Day$47.19–49.87 52W close$41.22–114.11 Avg vol 30d394K Short int964K · 8.1% float · 1.9d Short vol53% Last earningsAug 5, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 5 wks
filed Aug 4, 2026
call held Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$683.77M
Trailing 12 months
Net income (TTM)
$30.21M
Trailing 12 months
Revenue growth YoY
+21.9%
Year over year
Operating margin
5.7%
Trailing 12 months
P / E (TTM)
19.3
Trailing earnings · reciprocal yield 5.2%
FCF yield
8.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.6%
Year over year · fewer shares
Price change (1Y)
-49.4%
Trailing year
Short interest
8.1%
Latest settlement · 1.9 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Limbach reported Q2 results that fell short on margins and earnings but raised full-year 2026 revenue guidance to $760–$790 million while cutting adjusted EBITDA guidance to $78–$84 million, and closed the $30 million acquisition of CYMCOR to expand its data center platform.

Bullish
  • + Raised full-year 2026 revenue guidance to $760–$790 million from $730–$760 million.
  • + Closed the $30 million CYMCOR acquisition to expand data center capabilities with expected $12 million of 2027 program management revenue and $4 million of adjusted EBITDA.
  • + Generated $182.0 million of Q2 bookings for a 1.1x book-to-bill, the third consecutive quarter of strong bookings totaling $616 million.
  • + Operating cash flow reached $18.7 million, the second-highest second-quarter operating cash flow since becoming public.
  • + Expanded revolving credit facility to $125 million from $100 million, increasing liquidity and funding flexibility.
Bearish
  • − Cut full-year 2026 adjusted EBITDA guidance to $78–$84 million from $90–$94 million.
  • − Adjusted EBITDA fell 22.3% to $13.9 million from $17.9 million and adjusted diluted EPS declined to $0.64 from $0.93.
  • − Net income declined 38.8% to $4.7 million from $7.8 million, with diluted EPS falling to $0.39 from $0.64.
  • − ODR organic revenue declined 3.4%, reflecting ongoing softness in healthcare and institutional markets.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −35%
below
Price vs 50-day avg −7%
below
RSI (14) 46
neutral
MACD trend Positive
52-week position 11%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +9%
trailing
6-month return −42%
trailing
YTD return −37%
this year
Relative strength −54%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $52 › 200d $75 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +31 funds added
Insider flow Accumulating
Net +$515.9K over 90 days · 0% sells
Short interest Falling
8.08% of float · ▼ -0.5% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
180 holders — mid 3-yr range
Squeeze score 64
elevated · 0–100
Fundamentals
Excellent
Revenue growth +25%
Y/Y
Gross margin 26%
contracting
EPS growth +26%
Y/Y
Free cash flow $41.9M
Valuation P/E 20.7
below peers
Buyback $50.0M
authorized
Balance sheet $32.7M
net debt
Quant / Vol
risk profile
Very High
Volatility 73%
annualized · 1-yr
Max drawdown −64%
past year
ATR 5.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 4
Latest guidance · from the 8-K filed Aug 4, 2026
Revenue · FY 2026 Initiated $760M – $790M
prior FY $646.8M midpoint +19.8% Y/Y
Adjusted EBITDA · FY 2026 Non-GAAP Initiated $78M – $84M
ODR revenue as a percentage of total revenue · FY 2026 Initiated 70% – 80%
Total organic revenue growth · FY 2026 Non-GAAP Initiated 9% – 14%
ODR organic revenue growth · FY 2026 Non-GAAP Initiated 6% – 10%
SG&A expense as a percentage of total revenue · FY 2026 Initiated 15% – 16%
Free cash flow · FY 2026 Non-GAAP Initiated 75%
Guided vs delivered · last 4 settled
Revenue FY 2024
guided $515M – $535M
$518.78M In line
Revenue FY 2023
guided $490M – $520M
$516.35M In line
Revenues 2021
guided $480M – $510M
$490.35M In line
Revenue calendar year 2020
guided $560M – $600M
$568.21M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−35% Bearish
Price vs 50-day avg
−7% Bearish
RSI (14)
46 Neutral
MACD trend
Positive Bullish
52-week position
11% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $52 › 200d $75 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +31 funds added
Insider flow Accumulating
Net +$515.9K over 90 days · 0% sells
Short interest Falling
8.08% of float · ▼ -0.5% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
180 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $41 Now $49 · 11% Range high $114
vs 200-day avg -35% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Building Products & Equipment — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LMB
Limbach Holdings, Inc.
this stock
$613.90M -37.1% +24.7% 20.7 8.1%
TT
Trane Technologies plc
$99.99B +16.1% +5.6% 34.4 1.5%
JCI
Johnson Controls International plc
$91.64B +24.1% -4.2% 27.2 1.6%
CARR
CARRIER GLOBAL Corp
$46.00B +3.8% -3.3% 36.2 1.9%
CODGF
Compagnie De Saint Gobain
$37.80B -18.8% — — 0.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
180
% held
83.8%
Net QoQ
-322.6K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
217
View
Short & Settlement
Short Interest Falling
Shares short
964.0K
Days to cover
1.9d
Change
-4.6K sh
View
Short Volume
Short vol %
53%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
8.7K
Value
$435.1K
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
45.9%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Cluster buy
Net (90d)
+$515.9K
Buyers / Sellers
3 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$646.8M
Net income (FY)
$39.1M
EPS diluted
$3.23
View
Buybacks
Authorized
$50.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 9, 2026
This year
14
View
Proposed Sales
Value
$260.7K
Shares
5.1K
Filed
Sep 15, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
LMB -4.3% +9.2% -42.0% +18.7% -37.2%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -3.6% +9.1% -54.2% +19.3% -49.0%

Capital returns

Buyback program · as of Mar 2, 2026
Authorized
$50.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1606163 CUSIP 53263P105 13F (30d) 6 filings 6 filers Visit website Investor relations